Biotie Therapies terminates Newron Pharmaceuticals acquisition in a stock deal valued at $59.5M, plus contingent value rights

Newron Pharmaceuticals S.p.A.

Italy / Small-Cap Biopharma (<$1 billion)

$35.3m on 09/30/2011 [market cap]

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Biotie Therapies Corp.

Finland / Small-Cap Biopharma (<$1 billion)

$233.9m on 09/30/2011 [market cap]

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Canceled

Sample

01/01/2009

announced

01/01/2009

Canceled